The Tata Memorial Centre constitutes the
national comprehensive cancer entre for the prevention, treatment and research
on Cancer and is comparable to any similar center in the world. This achievement
has been possible due to the far-sighted and total support of the Department of
Atomic Energy, responsible for managing this Institution since 1962.
1932 when Lady Meherbai Tata died of leukaemia, after treatment abroad, Sir
Dorab Tata was determined to establish similar facilities for the treatment of
Cancer in India, initially planned for with a Radium Institute in Bombay. Sir
Dorab unfortunately died in 1932. Such was the commitment he made that the
Trustees of the Sir Dorab Tata Trust, along with various outstanding Cancer
specialists committed themselves in 1935 to the establishment of the centre that
would benefit the Nation with a more lasting value than the usual philanthropy .
Out of this humanitarian concept and commitment from the House of Tatas was born
the nucleus of a Hospital, in 1941, called the TATA MEMORIAL
The Tata Memorial
Hospital was initially commissioned 57 years ago in 1941 with a small eighty bed
Hospital. In 1952 the Indian Cancer Research Centre was established as a pioneer
research institute for basic research - later called the Cancer Research
Institute (CRI). In 1957 the Ministry of Health temporarily took over the Tata
Memorial Hospital. The transfer of the administrative control of the Tata
Memorial Centre (Tata Memorial Hospital and Cancer Research Institute) to the
Department of Atomic Energy in 1962 was the next major milestone. This was due
to the foresight and the vision of Dr. Homi Bhabha, who envisaged the major role
that radiation would play in cancer treatment - from imaging to staging and
actual therapy. The TMH and CRI merged as the two arms of the Tata Memorial
Centre (TMC) in 1966 represented a classic example of private philanthropy
augmented by Government support, with a mandate for Service, Education and
Research in Cancer.
It is important to remember the contributions of Dr.
J.C. Paymaster, Dr. E. Borges, Dr. D. Meher-Homji , Dr. D.J. Jussawalla, Dr.
V.R. Khanolkar, Dr. K.J. Randive and many others towards building this
Institute. In more recent times Dr. P.B. Desai, Dr. R.S. Rao, Dr. M.G. Deo, Dr.
A.N. Bhisey and Dr. K.A. Dinshaw have given impetus to the rapid progress. With
the total commitment of the DAE and successive Chairmen from Dr. H. Bhabha, Dr.
V. Sarabhai, Dr. H.N. Sethna, Dr. R. Ramanna, Dr. M.R. Srinivasan, Dr. P.K.
Iyengar and Dr. R.C. Chidambaram the Centre has rapidly expanded its functions
current activities of the Tata Memorial Hospital and the level of eminence
reached in its various spheres of expertise are worth recording. Nearly 25,000
patients visit the clinics annually not only from all over India but also from
neighbouring countries. Nearly 60% of these cancer patients receive primary care
at the Hospital of which over 70% are treated free of any charges. Over 1000
patients attend the OPD daily for medical advice, comprehensive care or for
follow-up treatment. The Hospital has expanded from a 80 bed Hospital covering
an area of 15,363 sq. meters to a 441-beds spread over 53,890 sq. meters. Our
Annual Budget was Rs.5 lacs in 1941 - today it runs close to Rs.28 crores.
Nearly 15,000 minor operations, 8500 major operations and 500 laser
surgeries are performed annually. About 5000 patients are treated with
Radiotherapy and Chemotherapy annually in multi-disciplinary programs delivering
Surgery remains the vital form of treatment
along with radiation therapy and chemotherapy. Much progress has been made
resulting in tremendous improvements in the overall survival of disease in many
The strategies for early diagnosis, treatment management,
rehabilitation, pain relief and terminal care have been established in a
comprehensive and multidisiplinary approach for a total cancer care
have taken place in every speciality. In surgery, the changing concepts have
taken into account the biology of cancer. Radical surgeries have yielded place
to more conservative surgery, with the very important objective of quality of
life, conserving function and organ without compromising the overall survival
outcomes. This has been very clearly proven in the early stage cancer of the
breast or tumours involving the soft tissue or bone, where amputative surgery
has been replaced by less radical procedures. Radiation therapy has also made
rapid advances with high technology, precision, computerization and newer
isotopes for therapy. Chemotherapy has played a very major role, with many new
drugs and clinical protocols investigated in clinical trials.
The TMH was
the first Centre in the country to initiate Bone Marrow Transplant in 1983. This
has been possible due to better total supportive care using better antibiotics,
nutritional, blood transfusion support, nursing and other areas.
important area of progress over the last few years has been radiological imaging
techniques using ultrasound, CT Scanners and more dynamic real time nuclear
Pathology has progressed from basic histopathology to
molecular pathology with emphasis on predictive assays for identifying the high
risk prognostic factors.
state-of-the-art equipment is available in every Department including the latest
Spiral CT Scanners, Gamma Cameras, Ultrasound, Microscopes, Linear Accelerators,
Simulators, Bone Marrow Transplantation facilities, ICU for critical care of
patients, updated Operation Theatres, sophisticated Blood Bank facilities and
laboratories. We are in a position to render high immunological, histochemical,
technological level of biochemical, cytological and pathological
Supportive care in the form of total rehabilitation, and
counselling of patients is widely recognised to be very important aspects of
therapy. Excellent work has been carried out in areas of Patient Rehabilitation,
physiotherapy, occupational therapy, speech therapy, psychology and medical
Preventive Oncology has a very major and important role to
play for early diagnosis, screening and down staging of cancer. Patient should
come in earlier stages, and high risk individuals should be sensitized and made
aware of signs and symptoms of cancer for early screening and examinations.
Public education and community based programmes have been strengthened as an
effective means of optimizing the impact of available resources.
Our Programs for Cancer awareness,
prevention, and control are well recognized and established with a satellite
Rural Cancer Centre at Barshi. Recently, awareness campaigns highlighting the
cancerous effects due to the sustained use of tobacco, banning the use of
tobacco in the entire Hospital complex, targeting school and College children by
educational programs highlighting the terrible effects of smoking and preventing
them from even starting the habit, are some of the activities in progress in the
Department of Preventive Oncology.
Well into the sixth decade of its
existence, the Tata Memorial Hospital remains the victim of its own prestige and
credibility generated over decades of hard and dedicated work. An Institution is
judged by the quality of the people who form the entire work-force. Our eminence
is entirely due to the unquestioned and total dedication of the entire staff in
the cause of fighting cancer regardless.
The long standing prestige of
the Institution needs to be fully supported to continue to deliver dependable
quality care in Cancer service, research and education of the highest
It is a tribute to the clinical and medical excellence of our
staff that our Hospital has been a Centre for multicentric research studies.
Currently we have studies conducted in collaboration with NCI, USA for treatment
of childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma; a
collaboration with IARC, France on an epidemiological study for neoplasms of the
lung and lymphatic and haemopoetic system and a large cohort study to detect
early cancers in women supported by the NIH, Washington. The new Clinical
Research Secretariat as a facility assists in the execution and co-ordination of
all these research activities, after review and sanction by the Scientific
Review Committee and the Ethics Committee. Simultaneously other international
collaborations for teaching and training with WHO, UICC, and IAEA have brought
recognition to the Centre, its 200 Doctors, 300 nurses and 200 Scientific
Officers. At any given time nearly 150 young students, medical professionals,
scientists or technicians are undergoing training and Continuing Educational
Programs, which impart knowledge, skills, and consultancy on a national
In line with recent advances in Information Technology, the Tata
Memorial Centre has about the best comprehensive computerization of Medical
Records and also improved communication by widening of the Electronic mail and
With the escalation and pressures on our entire
infrastructure, introduction of modern techniques of Hospital management are
required to ensure the least delay and discomfort to patients. We have therefore
introduced Professionals to review all our methods and systems for Total Quality
Management in all areas to make our own work-force and environment more amenable
for optimum performance.
The Cancer Research Institute plays an important
role with understanding of the molecular basis of cancer , Cell biology,
molecular epidemiology, laboratory medicine with predictive assays and molecular
pathology. Advances in developmental therapeutics with drugs, with different
modalities of treatment using different strategies, such as gene therapy,
vaccine, biological therapy and chemo prevention are being evaluated with
exciting possibilities for the future.
The Cancer Research Institute by
exemplary work has many firsts to its credit due to the dedicated leadership by
Dr. M.G.Deo and Dr.A.N. Bhisey. It has done pioneering research on gene therapy
of Cancer and in the development of transgenic mice. Its major emphasis
continues to be in cancers of the Head and Neck, aerodigestive tract, breast,
cervix and leukaemia - lymphomas. It continues to aim at understanding the
alteration in oncogenes, tumour suppressor genes and other growth factor genes
for use as markers. Products of protein and lipid peroxidations and DNA-protein
cross links have been noted to be markedly elevated in tissues of patients with
leukoplakia and oral cancer indicating induction of oxidative stress by tobacco.
A Western blot kit for AIDS has been developed at the CRI and its efficacy has
been tested in several laboratories in the Country. The TMC will actively
continue with the prime objectives of excellence in patient care, research and
education. However, there are practical limitations, for growth at our present
site in Parel. Major efforts are on to expand the infrastructure and facilities
in Parel itself to keep up with the needs and demands of the future. We are
seeking major funding for a composite package for expansion, upgradation and
modernisation programme. We need to procure new state of the art equipment in
all Departments and laboratories with renovation and refurbishing of the
existing buildings and wards. The Professional Education Division will
strengthen our training, education and academic programmes to continue our
objectives of developing human resource and trained personnel for the
The Department of Atomic Energy is also establishing a new
research centre in Navi Mumbai called the Advanced Centre for Treatment,
Research and Education in Cancer (ACTREC) . To focus on specific mission
oriented R&D activities in the area of cancer research this Centre was
conceived and approved to be completed in the Ninth Plan with a budget outlay of
71.28 crores. The first phase of ACTREC on 60 acres of land in Owe village has
already started and is expected to be commissioned by 1999.
This has been
planned as a state-of-the-art reseacrch center for cancers relevant to India and
South East Asia, and a deemed University for education in cancer prevention,
research and treatment. There comes a time in the life history of an Institution
where one needs to take a good look at the past to set guidelines for the
future. In a changing world, no organization can stand still. We need to reach
out in order to meet the demands of the future.
In the final analysis, an
Institution is judged by the quality of the people who form part of the entire
work force. Our eminence is entirely due to their unquestioned and total
dedication in the cause of fighting Cancer. The Tata Memorial Centre will not
rest on past achievements, splendid as they are, but will continue to give
succour to our patients, offer them the best chance of cure, of life, and relief
from pain in continuing tribute to the vision and dedication of those who have
guided the destiny of this Institution.